---
title: "Genrix Bio (688443.SH) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/688443.SH/norm.md"
symbol: "688443.SH"
name: "Genrix Bio"
parent: "https://longbridge.com/zh-HK/quote/688443.SH.md"
datetime: "2026-03-16T18:56:11.166Z"
locales:
  - [en](https://longbridge.com/en/quote/688443.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688443.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688443.SH/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/688443.SH/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/688443.SH/norm.md)


# Genrix Bio (688443.SH) — 財務報表

## 損益表 (CNY)

| 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.5615 | -0.1189 | -0.4599 | -0.3300 | -0.6789 |
| ROE | -45.56% | -9.57% | -35.19% | -23.40% | -44.82% |
| Revenue | 23.17M | 162.16M | 25.24M | 20.16M | 17.61M |
| Net income | -203.63M | -43.30M | -168.57M | -120.72M | -250.93M |
| Operating income | -151.91M | -54.82M | -177.85M | -144.72M | -247.72M |
| Gross margin | 153.35% | 97.24% | 82.38% | 82.93% | 80.10% |
| Net margin | -878.96% | -26.70% | -667.96% | -598.95% | -1425.16% |
| Profit quality | - | - | - | - | - |

## 資產負債表 (CNY)

| 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | - | 3.04B | 3.12B | 3.09B | 3.15B |
| Leverage | - | 1.70 | 1.70 | 1.54 | 1.48 |
| BVPS | 4.88 | 4.88 | 4.99 | 5.46 | 5.80 |
| Turnover | - | 0.0712 | 0.0235 | 0.0154 | 0.0089 |
| Cash & STI | 2.32B | 2.32B | 2.39B | 2.40B | 2.45B |
| Inv & Rec | - | 73.90M | 61.09M | 52.98M | 50.15M |
| LT assets | - | 458.09M | 459.65M | 431.63M | 441.55M |
| Net debt | -1.27B | -1.27B | -1.43B | -1.48B | -1.61B |

## 現金流量表 (CNY)

| 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | -145.13M | -5.38M | -110.69M | -152.93M |
| Investing CF | - | -199.84M | -31.34M | -304.32M | -9.82M |
| Financing CF | - | 81.62M | 23.38M | 70.72M | 48.78M |
| Free CF | - | -220.24M | 37.37M | -111.00M | 92.77M |
| OCF coverage | - | -872.03% | -7.83% | -727.82% | -370.75% |
| Repaid & issued | - | 94.52M | 57.62M | 85.11M | 86.15M |
| CapEx | - | -15.09M | -32.78M | -8.04M | -10.00M |